{
 "PrintNo":"S3048","Version":"A","Session":2021,"Chamber":"SENATE","BillType":"Senate",
 "Published":"2021-01-27T11:14:31.043216Z","Status":"IN_SENATE_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2022-04-28","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2021-01-27","Chamber":"SENATE"},
  {"Text":"REFERRED TO HEALTH","Date":"2022-01-05","Chamber":"SENATE"},
  {"Text":"AMEND (T) AND RECOMMIT TO HEALTH","Date":"2022-04-28","Chamber":"SENATE"},
  {"Text":"PRINT NUMBER 3048A","Date":"2022-04-28","Chamber":"SENATE","Version":"A"}
 ],
 "Sponsors":[{"ID":377,"Name":"Gustavo Rivera","Short":"RIVERA"}],
 "Title":"Relates to enacting the \"New York affordable drug manufacturing act\"",
 "Summary":"Enacts the \"New York affordable drug manufacturing act\" to direct the commissioner of health to enter into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs.",
 "LawSection":"Public Health Law","LawCode":"Add Art 2-A Title IV §§282 - 285, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to enacting the \"New York affordable drug manufacturing act\"",
 "PreviousVersions":["S9020-2019"]
}